Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of kinase inhibitors for targeted cancer therapies. Its structural features enable selective binding to enzyme active sites, enhancing drug efficacy. The compound's chiral center and fluorine substitution contribute to improved metabolic stability and bioavailability in final drug formulations. It is also employed in the preparation of antiviral drugs, where it helps modulate the pharmacokinetic profile of the active molecule. Commonly utilized in late-stage functionalization processes due to its compatibility with various coupling reactions in medicinal chemistry workflows.